Introduction {#S0001}
============

Radical cystectomy (RC) with urinary diversion (UD) is associated with significant morbidity. Once patients recover from this surgery, quality of life (QoL) becomes an important priority having a significant role in their future psychological and emotional well-being \[[1](#CIT0001)--[3](#CIT0003)\]. UD impacts QoL and there are different types of UD to choose from, including ileal conduit (IC) to continent cutaneous UD (CD) and neobladder (NB) \[[3](#CIT0003)--[8](#CIT0008)\].

Measuring QoL can help assess the impact of RC and UD, identify patient preference, help in staff training, and be useful for audit and clinical governance \[[1](#CIT0001)\]. The choice of UD depends on patient suitability and preference, with a possible surgical bias related to the surgical expertise available in the centre. Whilst enthusiasts favour NB, there is little evidence to support that one UD type is better than another \[[9](#CIT0009)--[12](#CIT0012)\]. It seems that for now, the choice of UD should be individualised and based on patient counselling and expectations, with an active but unbiased surgical input. Measuring QoL in these patients has changed from self-designed to non-validated and now validated tools, including generic and disease-specific measures. Over time the shift has been to use bladder cancer-specific health-related QoL (HRQoL) tools supplemented by patient-reported outcome measures \[[8](#CIT0008),[13](#CIT0013)--[18](#CIT0018)\].

Publication trends reflect clinical practice \[[19](#CIT0019)\]. Trends in the type of UD offered could help patients in their choice of UD type, improve counselling and allocation of healthcare resources. The QoL aspect seems to be the most important element in UD once patients have recovered from their initial surgery. There is no bibliometric study looking at the publication trends of reporting QoL in UD patients. We therefore assessed the trend in QoL reporting after RC and UD over the last four decades.

Materials and methods {#S0002}
=====================

Inclusion criteria {#S0002-S2001}
------------------

All studies reporting on QoL after UD, irrespective of the type of UD.Studies published in English language over the last four decades.

Exclusion criteria {#S0002-S2002}
------------------

Animal studies and case reports.Studies on UD that did not assess QoL.

Search strategy and study selection {#S0002-S2003}
-----------------------------------

We performed a systematic review of the world literature to identify original studies reporting on QoL in UD. It was carried out using Cochrane and Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology.

We searched PubMed, Medical Literature Analysis and Retrieval System Online (MEDLINE), Excerpta Medica dataBASE (EMBASE), Cumulative Index to Nursing and Allied Health Literature (CINAHL) and the Cochrane library for published studies from January 1980 to January 2017. We used the following search terms 'urinary diversion', 'quality of life', 'neobladder', 'ileal conduit', 'cutaneous diversion', 'cystectomy', 'health-related quality of life', and 'QoL'. All articles from 1980 to 1997, and only articles directly comparing two or more different UD types from 1998 to 2017 were selected for screening. All full-length articles published in the English language were included in the original search and the two reviewers (K.R., B.K.S.) independently identified all studies that fitted the inclusion criteria ([Figure 1](#F0001)).10.1080/2090598X.2019.1600279-F0001Figure 1.PRISMA flowchart of study inclusion.

We included all studies where patients underwent UD (1980--1997), and at least two forms of UD were used and QoL was measured using either a validated or non-validated questionnaire (1998--2017). After screening the abstracts (*n* = 295), 85 studies met the inclusion criteria and were included in our present review ([Appendix 1](#app0001)). Each of the 85 studies was then assessed in a standardised fashion. The following information was collected for each study: number of patients, type of UD compared, study design, type of instrument used to assess HRQoL outcome (general vs disease-specific and validated vs non-validated), major findings of the study, and any other characteristics unique to the study.

We divided the last four decades into three time periods: period-1 (1980**--**1997), period-2 (1998--2007), and period-3 (2008--2017).

Primary outcome measures {#S0002-S2004}
------------------------

Trends of QoL reporting over the last four decades.Number of studies and type of UD done.

Secondary outcome measures {#S0002-S2005}
--------------------------

Geographical variation in the reporting of the QoL studies.Journals which published these QoL studies.

Data extraction and analysis {#S0002-S2006}
----------------------------

Both reviewers (K.R., B.K.S.) independently identified all studies that appeared to fit the inclusion criteria and any disagreement was resolved with mutual consensus. All data were collected in an Excel spreadsheet and then transferred to a Word document. The study was carried out using the Cochrane and PRISMA methodology. Included studies showed a high level of heterogeneity and bias, and data were not suitable for a meta-analysis, and hence have been presented in a descriptive manner.

Results {#S0003}
=======

Over the last 37 years, a total of 85 post-RC QoL studies (8417 patients) have been reported ([Tables 1](#T0001) and [2](#T0002)). Of these UD patients (within the 85 studies), 3347 (39.8%) had an IC, 1078 (12.8%) had a CD, 3264 (38.8%) had a NB, and in the remaining 728 (8.6%) the type of UD was not specified ([Tables 1](#T0001) and [2](#T0002)). Whilst there were 15, 24 and 41 studies in period-1, period-2, and period-3, respectively, two (13%), 20 (83%) and 37 (90%) used a validated QoL tool; and none, six (25%) and 23 (56%) used a urology specific QoL tool during these three time periods. Similarly, the number of prospective studies increased from one (7%) to four (17%) and 14 (34%) in these three time periods.10.1080/2090598X.2019.1600279-T0001Table 1.The number of studies and types of UD performed over the last four decades (five studies were overlapping\*).YearNo. of countries (studies\*)No. of patientsValidated scale (urology specific) used, *n*Prospective/retrospective, *n*IC/CD/NB/unspecified, *n*Open/lap or robotic, *n*1980--19976 (15)12062 (0)1/14784/368/54/01206/01998--200711 (24)246420 (6)4/20899/428/1105/322432/02008--201718 (41)474737 (23)14/271664/282/2105/6963939/112Total35 (80)841759 (29)19/613347/1078/3264/7287577/112[^1] 10.1080/2090598X.2019.1600279-T0002Table 2.QoL of the included UD studies over the last four decades ([Appendix 1](#app0001)). JournalAuthorCountryYearNo. of PatientsScale used -- 1Scale used 2ICCDNBCD/NBStudy typeConclusion on QoL1*Br J Urol*Jones *et al.*UK198034Self-designed questionnaire 34   Retro.Stoma problems2*Scand J Urol Nephrol*Fosså *et al.*Norway198759Self -- psychological/social issues 59   Retro.Good QoL3*J Urol*Boyd *et al.*USA1987172BDI, POMS, physical impact 8785  Retro.Preop. counselling important, patients overall satisfied but more for CD4*Br J Urol*Månsson *et al.*Sweden198860Self-designed questionnaire 4020  Retro.Less stoma problems and more freedom for activities in CD5*Scand J Urol Nephrol*Mommsen *et al.*Denmark198968Self-designed questionnaire 68   Retro.Preop. counselling important but often neglected6*Br J Urol*Chadwick and StowerUK199041Interview -- appliance management 41   Retro.83% improved QoL, 90% continue household duty, leakage problem7*Scand J Caring Sci*Månsson *et al.*Sweden199134Interview 2014  Retro.Sexual problems postop., lack of psychological support from health services -- irrespective of UD8*Br J Urol*Nordström *et al.*Sweden199266Interview -- sexual function 66   Retro.90% men had erectile dysfunction, 5/6 females had lower sexual activity9*Scand J Urol Nephrol*Nordström *et al.*Sweden199266Interview -- psychological function 66   Retro.80% overall good health, 70% unchanged social activity, leak, body image in females10*Scand J Urol Nephrol*Bjerre *et al.*Denmark199476Self-designed questionnaire 5026  Retro.Global satisfaction high and similar in both groups11*Br J Urol*Bjerre *et al.*Denmark199567Interview + questionnaire 29 38 Retro.High global satisfaction with both UDs, Urinary leak more frequent in NB, but IC patients affected more12*J Urol*Gerharz *et al.*Germany1997192Self-designed questionnaire 13161  Retro.Less stoma problems in CD, overall scores similar13*Int J Urol*Okada *et al.*Japan1997137Self-designed questionnaire 6374  Retro.Less stoma problems in CD, but more night catheterisations, more satisfied patients in CD, counselling/consent14*Eur Urol*Filipas *et al.*Germany199781Interview + questionnaire 2754  Retro.No difference in global satisfaction and health, UD type must consider psychological and employment status15*Scand J Urol Nephrol*Bjerre *et al.*Denmark199737Self-designed questionnaire 2017  Retro.No difference in two groups16*Br J Urol*Månsson *et al.*Sweden199750SIPMCT171716 Pros.Defensive strategies and philosophical outlook generally did not influence the psychosocial outcome of intervention17*Scand J Urol Nephrol*Bjerre *et al.*Denmark199876Self-designed questionnaire 27 49 Retro.No difference in two groups18*Urology*Weijerman *et al.*The Netherlands199856SIP  2333 Retro.Overall QoL favourable in both groups19*Br J Urol*Sullivan *et al.*Canada199886Urinary symptoms, activity level, overall wellbeing  4244 Retro.Good overall QoL, significant effect on sex life, 70% patients had no limit on activities20*Br J Urol*Månsson *et al.*Sweden199857Interview + questionnaireMCT + VAS172218 Pros.Patients with wet stoma did not do less well than continent procedures, and the adjustment improved with time21*J Urol*Hart *et al.*USA19992244 self-reporting questionnaire 2493103 Retro.Good overall QoL in all groups22*Int J Urol*Kitamura *et al.*Japan199979EORTC QLQ-C30Self-designed questionnaire362221 Retro.Little difference in all groups, patients accepted and adapted to present general quality status23*Qual Life Res*Hardt *et al.*Germany200044SF-36FLZM2420  Pros.High global satisfaction with both UDs, 75% would choose same UD again24*Ann Surg Oncol*McGuire *et al.*USA200092SF-36 381638 Retro.IC patients have decreased mental QoL but continent UDs do not, compared to population norms25*Urology*Fujisawa *et al.*Japan200056SF-36 20 36 Retro.No difference in two groups26*World J Urol*Hobisch *et al.*Austria2000102EORTC QLQ-C30Self-designed questionnaire33 69 Retro.QoL better with NB in all domains27*Eur Urol*Kulaksizoglu *et al.*Turkey200268EORTC QLQ-C30BDI49215 Pros.Psychological and HRQoL measures come to baseline values and stabilise after the 12th-month period28*BJU Int*Månsson *et al.*Sweden200264FACT-BLHADS 3529 Retro.No difference overall between groups (NB -- more incontinence, but better appreciation of appearance and erectile function)29*BJU Int*Hara *et al.*Japan200285SF-36 37 48 Retro.Patients satisfied with overall QoL and health status in both groups30J UrolDutta *et al.*USA200272SF-36FACT-G23 49 Retro.NB marginally better when adjusted for age, stage and sex31*Eur Urol*Henningsohn *et al.*Sweden2003395Self-designed questionnaire 2188889 Retro.Compromised sexual function main source of distress in RC patients, addressing self-assessed distress may improve patient care32*BJU Int*Protogerou *et al.*Greece2004108EORTC QLQ-C30Self-designed questionnaire58 50 Retro.QoL same in both groups. Higher emotional function compared to NB population but more urinary + sexual problems33*Eur Urol*Joniau *et al.*Belgium200558Self-designed questionnaire   58 Retro.ONB substitution has acceptable impact on patient's everyday life.34*J Urol*Yoneda *et al.*Japan200548SF-36FACT-Bl  48 Retro.No difference in HRQoL between patients and controls35*Cancer*Allareddy *et al.*USA200682FACT-BL 56  26Retro.No difference in IC vs continent UD; no major difference between non-RC and RC patients36*Jpn J Clin Oncol*Kikuchi *et al.*Japan200649FACT-BL 201415 Retro.QoL -- no difference; body image and urinary function affected. 10/13 IC, 7/9 CD, 6/7 NB would choose same operation again37*Int J Urol*Harano *et al.*Japan200741SF-36Urinary continence questionnaire 2021 Retro.HRQoL in the NB group and those in the CD group were similar38*Cancer*Gilbert *et al.*USA2007188BCI 66 122 Retro.More urinary leak in NB39*Acta Med Okayama*Saika *et al.*Japan2007109EORTC QLQ-C30Patient satisfaction563122 Retro.No difference in HRQoL, more patients disappointed with NB -- preop. counselling40*Urology*Månsson *et al.*Sweden200761FACT-BLHADS  61 Pros.Swedish men had better FACT-BL and HADS scores, patient assessed outcome differ with different populations41*Eur J Surg Oncol*Autorino *et al.*Italy200879SF-36 44 35 Retro.No significant difference in scores between IC and NB. Compared to control population -- physical, social and emotional functioning worse in both IC and NB groups42*Urology*Sogni *et al.*Italy200885EORTC QLQ-C30EORTC QLQ-BLM3053 32 Retro.No difference in QoL or complications and survival43*BJU Int*Yuh *et al.*USA200934FACT-BL 34   Pros.Pre- and post-RC QoL, postop. QoL scores similar at 3 months and exceeded baseline at 6 months44*Scand J Urol Nephrol*Frich *et al.*Norway200972Self-designed questionnaire 37 35 Retro.Patients with all UDs rated their QoL as high with no significant difference between them. More patients in NB group experienced practical problems compared to IC. Influence on everyday life was significantly better in favour of IC compared to NB.45*Ann R Coll Surg Engl*Philip *et al.*UK200952SF-36 24 28 Retro.NB patients were younger and more fit. HRQoL was favourable in both UDs, with physical functioning significantly better in NB group. Conclude -- body image issues persist although no formal body image measures used.46*Urology*Somani *et al.*UK200932SWLSEORTC QLQ-C3029 3 Pros.No difference in scores between IC and NB47*BJU Int*Miyake *et al.*Japan201080SF-36   80 Retro.HRQoL similar except physical health, emotional problems and bodily pain, which were worse in NB patients. No difference between men and women.48*J Urol*Large *et al.*USA201040FACT-VCI  1921 Retro.Women undergoing RC with ONB vs IP have similar HRQoL outcomes49*Urology*Hedgepeth *et al.*USA2010336BCIBIS85 139 Pros.Longest F/U -- 8 years. Initial worsening of body image in both UDs. Earlier return of body image to baseline for IC, with NB never returning to baseline. Age but not sex associated with body image with older patients having better body image50*Int Urol Nephrol*Vakalopoulos *et al.*Greece201139FACT-GFACT-VCI; BDI; SF-36 1425 Retro.Patients with UUC surprisingly presented at least equal QoL than the presumably less debilitating ONB51*ISRN Urol*Erber *et al.*Germany2012301EORTC QLQ-C30BLM30146 115 Retro.Many arguments in favour of NB rather than IC as the UD of choice.52*Urology*Anderson *et al.*USA2012190FACT-VCI 70 101 Retro.Patients with IC had VCI scores that averaged 5 points \> than those who had an ONB UD at 1-year postop.53*Eur J Surg Oncol*Miyake *et al.*Japan2012212SF-36   212 Retro.HRQoL with NB is generally favourable irrespective of the type of NB54*Urology*Stegemann *et al.*USA201291CARE questionnaire 84 6 Pros.Initial decline in QoL after surgery but approached preoperative baseline levels at ≤90 days55*Cir Esp*Mucciardi *et al.*Italy201358EORTC QLQ-C30  58  Retro.Cutaneous ureterostomy represents a valuable alternative for elderly patients with high surgical risk56*Acta Inform Med*Prcic *et al.*Bosnia & Hersegovina2013106SIP 662020 Pros.NB provides significantly better QoL than IC57*Korean J Urol*Shim *et al.*South Korea201342K-BISAuthor-constructed questionnaire13 29 Retro.NB was associated with significantly better body image than IC58*Mol Clin Oncol*Yang *et al.*China201382SF-36Continence questionnaire (NB group only) 2854 Pros.SF-36 scores were significantly greater following NB than non-NB -- total health scores were higher59*Can J Urol*Metcalfe *et al.*Canada201384FACT-VCI 53 31 Retro.No statistically significant association between the type of UD and QoL60*Urol Ann*Asgari *et al.*Iran2013149Author-constructed questionnaire 701663 Pros.Global satisfaction was higher with CD and NB compared with IC. Continent UD provides better results in terms of QoL compared to IC61*Cent Eur J Urol*Aboumarzouk *et al.*Poland201363Assessment based on psychological, social, sexual and physical states (no particular scale used) 39 24 Pros.No difference between the groups regarding QoL; no difference between either UD in all comparative aspects e.g. length of hospital stay, complications etc., except that the NB had a longer operative time62*Health Qual Life Outcomes*Gacci *et al.*Italy201337EORTC QLQ-C30FACT-BL and QLQ-BLM3016129 Retro.Patients with cutaneous ureterostomy had worse HRQoL compared to those who underwent IC or NB, primarily due to physical/emotional perception of body image.63*J UrolParekh* et al.USA201340      Pros. 64*Arch Esp Urol*Fuentes *et al.*Spain201425FACT-Bl 2193 Retro.Ureterosigmoidostomy may be a good choice for UD in selected patients, with similar QoL to other types of UD65*Urol Oncol*Miyake *et al.*Japan2014234SF-36   234 Retro.Both types resulted in satisfactory outcomes; sigmoid NB group appeared to be more favourable than ileal NB group in terms of long-term voiding function66*Ann Surg Oncol*Rouanne *et al.*France201431SF-12Urinary symptom profile/Contilife questionnaire  31 Retro.Ileal NB reconstruction provides long-term satisfaction with maintained HRQoL67*BJU Int*Singh *et al.*India2014164EORTC QLQ-C30 80 84 Pros.NB better QoL outcomes than IC68*Urology*Large *et al.*USA201473FACT-VCI 27 16 Pros.Scores did not statistically differ from baseline to 6-month follow-up between UD types69*Urology*Aboumohamed *et al.*USA2014182BCIBIS182   Retro.RARC has comparable HRQoL outcomes to open RC; UD technique does not appear to affect QoL70*BJU Int*Poch *et al.*USA201443BCIEORTC-BIS38 5 ?HRQoL outcomes after RARC show recovery of urinary and bowel domains at ≤6 months71*Int J Urol*Zahran *et al.*Egypt201474EORTC QLQ-C30FACT-Bl  74 Retro.After ONB in women, HRQoL is lower than that of the normal population -- night time incontinence being a particular issue72*World J Urol*Mischinger *et al.*Germany201456SF-36QLQ-C30 + QLQ-BLM30 + TNQ  56 Pros.Contradictory results -- suggest that the questionnaires are not useful to evaluate HRQoL in patients with different NBs73*BJU Int*Messer *et al.*USA201440FACT-VCI 37 3 Pros.HRQoL returns to baseline 3 months post-RC, with no signiﬁcant diﬀerence in HRQoL between open RC and RARC74*BMC Urol*Huang *et al.*China2015294EORTC-QOLBIS, BCI78 39 Retro.The mean BIS score in ileal ONB group patients was significantly better than that in IC group patients at the 1-year follow-up, but there was no significant difference at the long-term follow-up.75*Urol Oncol*Goldberg *et al.*Israel201595BCI 49 46 Retro.Increased risk of urinary incontinence and sexual dysfunction for NB reconstruction vs IC76*Eur Urol*Bochner *et al.*USA2015124Self-designed questionnaireGlobal health, side effects, emotional27 (r), 23 (o)0 (r), 3(o)33 (r) 32 (o)Pros.There were no clinical or statistical differences between the two arms in QoL change from baseline to 3 month or from 3 to 6 months in any of the evaluated domains77*Eur Urol*Satkunasivam *et al.*USA2016107Modified BCI, SF-36mucus- and pad-related questions included  28 (r), 79 (o)Retro.Ileal ONB had comparable bladder cancer-specific HRQOL scores to open ONB. However, pad size and daytime wetness were worse for ileal ONB, albeit over a significantly shorter follow-up78*BJU Int*Longo *et al.*Italy201670BCI -- translated to ItalianLikert scale, BCI assessed stoma and appliance function3535  Retro.Chronic ureteric stenting does not affect the QoL of patients with bladder cancer undergoing CD compared with those undergoing IC UD.79*Oncol Lett*Liu *et al.*China201685Karnofsky performance scale (functional), FACT-G, BSS 2728 (traditional), 30 (tubeless)Retro.The HRQoL scores of the patients in the improved group were significantly higher than those of the patients in the other two groups, and the difference was statistically significant80*Eur Urol*Khan *et al.*UK2016164FACT-BlBCa; Bladder Cancer Subscale17 (o), 3 (r), 18 (l)3 (o), 2 (r), 1 (l)Pros.There were no statistically significant relationships in QoL according to surgical arm (o, open; r, robotic; l, laparoscopic)81*J Urol*Winters *et al.*USA2018166      Retro. 82*Minerva Urol Nefrol*Zahran *et al.*Egypt2017145EORTC-QLQ-C30 (translated to Arabic)FACT-Bl64 84 Retro.In women, HRQoL is better after ONB than IC as long as continence status is preserved. If incontinence is expected, IC may be a better option for UD.83*Urology*Gellhaus *et al.*USA2017128BCI 44 4836 (IP)Retro.Urinary function but not urinary bother was significantly better in IC and IP compared to NB UDs. Older men with IC had better urinary function than older men with NB. In younger men, IP patients had significantly better urinary function than NB patients.84*Eur J Surg Oncol*Mischinger *et al.*Germany201756GIQLI    23 (Studer) 33(I-pouch)Retro.No significant differences in postoperative bowel disorders were found between both NB types85*World J Urol*Kretschmer *et al.*Germany2017121EORTC--QLQ-C30 -- German translationICIQ-SF questionnaire50 50 Retro.ONB is an independent predictor for better overall HRQoL at 3 months, but not 12 months after RC (global health score, physical functioning, role functioning)[^2]

The overall proportion of reported IC patients reduced from 65% (784 patients) to 36% (899) and 35% (1664) from period-1 to period-3, whereas the proportion of reported NB patients increased from 4.5% (54) to 44% (1105) and 44% (2105). The reporting of both the UD types was broadly similar over the last two decades. Over the last few years there have also been QoL studies on laparoscopic and robot-assisted IC and NB UDs.

Overall, 43 (51%) studies came from Europe, 22 (26%) from the USA, and 16 (19%) from Asia ([Table 3](#T0003)), with 16 studies published in *BJU International* (*British Journal of Urology* before 1999) and 10 studies in *Urology*.10.1080/2090598X.2019.1600279-T0003Table 3.Geographical density and impact of studies over the last four decades.YearNumber and countryNumber and continentNumber and Journal1980--19975 -- Sweden\
4 -- Denmark\
2 -- UK, Germany\
1 -- USA, Japan, Norway14 -- Europe\
1 -- USA, Asia5 -- *Br J Urol (BJU Int)*\
3 -- *J Urol*\
1 -- *Eur Urol, Int J Urol*1998--20077 -- Japan\
5 -- USA\
4 -- Sweden\
1 -- Germany, Denmark, Netherlands, Canada, Austria, Turkey, Greece, Belgium11 -- Europe\
7 -- Asia\
6 -- USA5 -- *BJU Int*\
3 -- *Urology, J Urol*\
2 -- *Int J Urol, Eur Urol, Cancer*2008---201714 -- USA\
5 -- Italy\
4 -- Germany\
3 -- UK, Japan, China\
2 -- Egypt\
1 -- Norway, Greece, Bosnia, South Korea, Canada, Iran, Poland, Spain, France, India, Israel18 -- Europe\
15 -- USA\
8 -- Asia\
2 -- Africa\
1 -- Middle East7 -- *Urology*\
6 -- *BJU Int*\
3 -- *Eur Urol, Eur J Surg Oncol*\
2 -- *World J Urol, Urol Oncol*

Discussion {#S0004}
==========

Over the last decade, there have been more QoL studies and more validated and prospective studies. Similarly, the proportionate numbers of NBs has also increased over the last two decades, with newer studies now reporting on laparoscopic and robot-assisted UDs ([Tables 1](#T0001) and [2](#T0002)). There has also been a rise in the number of studies reporting on QoL outcomes in these patients, demonstrating the importance placed on QoL in the last decade.

Change in QoL trends over the last four decades {#S0004-S2001}
-----------------------------------------------

Whilst publication trends show that better reporting of QoL with more validated questionnaires are now being used, it seems that as long as the patient is well counselled and supported in their decision they learn to cope and adjust with their UD type \[[1](#CIT0001)\].

Compared to previous decades, the past decade has seen an upsurge in focus on QoL outcomes in bladder cancer. This has occurred in tandem with the development of new and specific HRQoL instruments used in bladder cancer \[[1](#CIT0001),[8](#CIT0008)\]. There has also been considerable variability in the use of QoL assessment tools, with a progressive uptake of validated assessment methods in the last decade. Our literature review revealed 13 of the 15 studies between 1987 and 1997 used a non-validated ad hoc (self-designed) instrument to assess QoL outcomes compared to only four in the 2009--2017 period. This suggests that the process of HRQoL measurement is becoming increasingly popular and perhaps clinically responsive.

The ad hoc instruments previously used were potentially poor measures of reliability and qualitative outcomes, and subject to bias due to their inherent non-validated nature \[[1](#CIT0001),[8](#CIT0008)\]. In addition, there has been a gradual rise in the globalisation of quality assessment in patients after RC, given that 18 different countries are represented across the studies in 2009--2017 compared to only six in 1987--1997. Only one study across the last three decades accounted for sociocultural influences in health perception and QoL evaluation \[[11](#CIT0011)\]. Perhaps there is a role for cross-cultural testing of these QoL instruments to ensure the validity and reliability of these tools across patients from other countries and cultures \[[12](#CIT0012)\].

Generic vs cancer-specific QoL assessment {#S0004-S2002}
-----------------------------------------

In the past more generic QoL assessment tools were used. Previously, the Beck Depression Inventory (BDI) and Sickness Impact Profile (SIP) \[[13](#CIT0013)\] were used to assess HRQoL across a wide range of medical conditions, and therefore these were not responsive to finer, qualitative, postoperative changes pertinent to bladder cancer and UD. Similarly, the 36-item short-form health survey (SF-36) \[[14](#CIT0014)\], which was commonly used in this time period did not incorporate postoperative concerns specific to bladder surgery, including issues such as erectile dysfunction or urinary incontinence. Indeed, even cancer-specific scales \[European Organisation for the Research and Treatment of Cancer Quality of Life 30-item core questionnaire (EORTC QLQ-30C) \[[15](#CIT0015)\] and Functional Assessment of Cancer Therapy-General (FACT-G) \[[16](#CIT0016)\]\] failed to address specific domains of importance to patients with bladder cancer.

The importance of developing instruments that measure specific outcomes for patients with bladder cancer is slowly being addressed as demonstrated by the fact that 23 studies from 2009 onwards used a bladder-specific QoL tool. Tools such as the FACT-Bladder Cancer (FACT-BL), Bladder Cancer Index (BCI) \[[17](#CIT0017)\], Body Image Scale (BIS), FACT-Vanderbilt Cystectomy Index (FACT-VCI) \[[18](#CIT0018)\], suggest a greater appreciation for having a responsive tool that can identify specific concerns in post-RC patients and hopefully act as a framework to compare outcomes and validate more specific tools.

Despite several retrospective studies reporting no clear superiority for NB surgery \[[17](#CIT0017),[20](#CIT0020)--[23](#CIT0023)\], recent data suggest that NB is increasingly being offered to patients. Although the type of UD should be individualised, the surgeon or centre should be able to offer both types of UDs for surgical equipoise, based on patient preference.

[Table 1](#T0001) suggests a progressive increase in the number of prospective studies being performed in the last decade, along with a rise in the reported numbers of NB UDs. We can perhaps postulate that the shift towards NBs has predominantly been driven by improved surgical training in a more complex procedure and better patient counselling, offering a choice of UD rather than the QoL outcomes \[[24](#CIT0024)\].

Role of laparoscopic and robot-assisted surgery in post-RC QoL {#S0004-S2003}
--------------------------------------------------------------

The advent of minimally invasive surgery, such as robot-assisted RC (RARC) and laparoscopic surgery, has led to decreased length of stay and morbidity, and faster recovery. Multicentre data from the USA has suggested a significant rise in its use from 0.6% in 2004 to 12.8% in 2010 \[[2](#CIT0002),[3](#CIT0003),[25](#CIT0025)\]. Poch et al. \[[26](#CIT0026)\] assessed QoL before and after RARC and reported no significant QoL advantage for RARC. However, the authors found quicker return of urinary function and better body image postoperatively with intracorporeal vs extracorporeal UDs. Studies have failed to show a QoL benefit of RARC compared to open RC \[[2](#CIT0002),[27](#CIT0027)\]. A recent meta-analysis also suggests postoperative HRQoL to be similar in patients undergoing RARC and open RC \[[28](#CIT0028)\]. With the advent of enhanced recovery after surgery (ERAS) protocols, there is now a reduction in postoperative morbidity and hospital stay, with a recent study reporting higher emotional well-being in patients who underwent ERAS \[[29](#CIT0029)\].

Strengths and limitations of the review {#S0004-S2004}
---------------------------------------

Despite the current trend of QoL studies moving in the right direction with the increased use of validated and specific HRQoL measures; the fact remains that there are still significant challenges in measuring QoL in UD patients. Sexual dysfunction although common is perhaps poorly captured. Conversely, although disease-specific questionnaires are more responsive than generic questionnaires to subtle changes within disease-specific domains, the high disease-specific sensitivity of these questionnaires may limit the ability to account for unexpected events. For example, an unanticipated neurological adverse event may not be addressed in the disease-specific instrument's questions and as a result this may not be reflected in an accurate QoL change. Of the newer QoL tools, the Bladder Utility Symptom Scale (BUSS) seems to be a novel patient-reported outcome instrument and measures HRQoL for all patients with bladder cancer regardless of treatment received or stage of the disease \[[30](#CIT0030)\].

Various studies have been published investigating QoL after RC and UD. However, there is an extensive deal of heterogeneity amongst these studies with regards to methodology, the use of non-validated QoL instruments, and the underpowered and retrospective nature of the majority of data make interpretation difficult. Based on the present studies, QoL has not shown to be significantly variable across the different types of UD. As the majority of them are retrospective in nature, there also remains the risk of inherent selection bias. Furthermore, QoL is only measured postoperatively in most of these studies, and in the absence of preoperative QoL data, it is not truly possible to determine the effect of UD. With different approaches to UD and in the absence of any randomised trials, results from the ongoing prospective, multicentre, randomised trial of open vs robotic radical cystectomy (RAZOR) trial may provide an answer in the near future \[[31](#CIT0031)\].

Conclusion {#S0005}
==========

The last four decades has seen gradual but significant improvements in the way QoL assessment is conducted in RC patients, with the implementation of several validated, bladder cancer-specific questionnaires and UD-specific constructs. The emergence of more prospective studies with validated QoL instruments has improved our ability to identify their QoL and to understand the differences between various UD types.
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